Estudos de fase 3 com tapinarofe em creme para psoríase em placas.

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis – New England Journal of Medicine

Comentário: Topical tapinarof reduces severity of plaque psoriasis – HealthDay

Comentário no Twitter

In two trials of treatment for psoriasis with the topical aryl hydrocarbon receptor–modulating agent tapinarof, clearance of lesions occurred in a larger proportion of patients who used tapinarof cream than of those who used placebo. https://t.co/I4zgVFELhz pic.twitter.com/qT6lbaJK0U

— NEJM (@NEJM) December 10, 2021